Cassava Sciences Reports Q3 2024 Financial and Operating Results

Go back to Cassava Sciences Reports Q3 2024 Financial and Operating Results

Cassava Sciences, Inc. (SAVA) Tops Q3 EPS by 15c

November 7, 2024 7:56 AM EST

Cassava Sciences, Inc. (NASDAQ: SAVA) reported Q3 EPS of ($0.58), $0.15 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Cassava Sciences, Inc. (SAVA) click here.

... More